Global Post Herpetic Neuralgia Therapies Market Research Report 2024(Status and Outlook)
Report Overview:
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
The Global Post Herpetic Neuralgia Therapies Market Size was estimated at USD 1660.19 million in 2023 and is projected to reach USD 2088.58 million by 2029, exhibiting a CAGR of 3.90% during the forecast period.
This report provides a deep insight into the global Post Herpetic Neuralgia Therapies market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Post Herpetic Neuralgia Therapies Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Post Herpetic Neuralgia Therapies market in any manner.
Global Post Herpetic Neuralgia Therapies Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Endo Pharmaceuticals
Depomed
Acorda Therapeutics
Pfizer
Mylan
Daiichi Sankyo
Teikoku Pharma
Market Segmentation (by Type)
Drugs
Patches
Steroid Injectable
Market Segmentation (by Application)
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Post Herpetic Neuralgia Therapies Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
The Global Post Herpetic Neuralgia Therapies Market Size was estimated at USD 1660.19 million in 2023 and is projected to reach USD 2088.58 million by 2029, exhibiting a CAGR of 3.90% during the forecast period.
This report provides a deep insight into the global Post Herpetic Neuralgia Therapies market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Post Herpetic Neuralgia Therapies Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Post Herpetic Neuralgia Therapies market in any manner.
Global Post Herpetic Neuralgia Therapies Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Endo Pharmaceuticals
Depomed
Acorda Therapeutics
Pfizer
Mylan
Daiichi Sankyo
Teikoku Pharma
Market Segmentation (by Type)
Drugs
Patches
Steroid Injectable
Market Segmentation (by Application)
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Post Herpetic Neuralgia Therapies Market
- Overview of the regional outlook of the Post Herpetic Neuralgia Therapies Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Post Herpetic Neuralgia Therapies Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Post Herpetic Neuralgia Therapies
1.2 Key Market Segments
1.2.1 Post Herpetic Neuralgia Therapies Segment by Type
1.2.2 Post Herpetic Neuralgia Therapies Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 POST HERPETIC NEURALGIA THERAPIES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Post Herpetic Neuralgia Therapies Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Post Herpetic Neuralgia Therapies Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 POST HERPETIC NEURALGIA THERAPIES MARKET COMPETITIVE LANDSCAPE
3.1 Global Post Herpetic Neuralgia Therapies Sales by Manufacturers (2019-2024)
3.2 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Manufacturers (2019-2024)
3.3 Post Herpetic Neuralgia Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Post Herpetic Neuralgia Therapies Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Post Herpetic Neuralgia Therapies Sales Sites, Area Served, Product Type
3.6 Post Herpetic Neuralgia Therapies Market Competitive Situation and Trends
3.6.1 Post Herpetic Neuralgia Therapies Market Concentration Rate
3.6.2 Global 5 and 10 Largest Post Herpetic Neuralgia Therapies Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 POST HERPETIC NEURALGIA THERAPIES INDUSTRY CHAIN ANALYSIS
4.1 Post Herpetic Neuralgia Therapies Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF POST HERPETIC NEURALGIA THERAPIES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 POST HERPETIC NEURALGIA THERAPIES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Post Herpetic Neuralgia Therapies Sales Market Share by Type (2019-2024)
6.3 Global Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2019-2024)
6.4 Global Post Herpetic Neuralgia Therapies Price by Type (2019-2024)
7 POST HERPETIC NEURALGIA THERAPIES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Post Herpetic Neuralgia Therapies Market Sales by Application (2019-2024)
7.3 Global Post Herpetic Neuralgia Therapies Market Size (M USD) by Application (2019-2024)
7.4 Global Post Herpetic Neuralgia Therapies Sales Growth Rate by Application (2019-2024)
8 POST HERPETIC NEURALGIA THERAPIES MARKET SEGMENTATION BY REGION
8.1 Global Post Herpetic Neuralgia Therapies Sales by Region
8.1.1 Global Post Herpetic Neuralgia Therapies Sales by Region
8.1.2 Global Post Herpetic Neuralgia Therapies Sales Market Share by Region
8.2 North America
8.2.1 North America Post Herpetic Neuralgia Therapies Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Post Herpetic Neuralgia Therapies Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Post Herpetic Neuralgia Therapies Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Post Herpetic Neuralgia Therapies Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Post Herpetic Neuralgia Therapies Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Endo Pharmaceuticals
9.1.1 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Basic Information
9.1.2 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Product Overview
9.1.3 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Product Market Performance
9.1.4 Endo Pharmaceuticals Business Overview
9.1.5 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies SWOT Analysis
9.1.6 Endo Pharmaceuticals Recent Developments
9.2 Depomed
9.2.1 Depomed Post Herpetic Neuralgia Therapies Basic Information
9.2.2 Depomed Post Herpetic Neuralgia Therapies Product Overview
9.2.3 Depomed Post Herpetic Neuralgia Therapies Product Market Performance
9.2.4 Depomed Business Overview
9.2.5 Depomed Post Herpetic Neuralgia Therapies SWOT Analysis
9.2.6 Depomed Recent Developments
9.3 Acorda Therapeutics
9.3.1 Acorda Therapeutics Post Herpetic Neuralgia Therapies Basic Information
9.3.2 Acorda Therapeutics Post Herpetic Neuralgia Therapies Product Overview
9.3.3 Acorda Therapeutics Post Herpetic Neuralgia Therapies Product Market Performance
9.3.4 Acorda Therapeutics Post Herpetic Neuralgia Therapies SWOT Analysis
9.3.5 Acorda Therapeutics Business Overview
9.3.6 Acorda Therapeutics Recent Developments
9.4 Pfizer
9.4.1 Pfizer Post Herpetic Neuralgia Therapies Basic Information
9.4.2 Pfizer Post Herpetic Neuralgia Therapies Product Overview
9.4.3 Pfizer Post Herpetic Neuralgia Therapies Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Recent Developments
9.5 Mylan
9.5.1 Mylan Post Herpetic Neuralgia Therapies Basic Information
9.5.2 Mylan Post Herpetic Neuralgia Therapies Product Overview
9.5.3 Mylan Post Herpetic Neuralgia Therapies Product Market Performance
9.5.4 Mylan Business Overview
9.5.5 Mylan Recent Developments
9.6 Daiichi Sankyo
9.6.1 Daiichi Sankyo Post Herpetic Neuralgia Therapies Basic Information
9.6.2 Daiichi Sankyo Post Herpetic Neuralgia Therapies Product Overview
9.6.3 Daiichi Sankyo Post Herpetic Neuralgia Therapies Product Market Performance
9.6.4 Daiichi Sankyo Business Overview
9.6.5 Daiichi Sankyo Recent Developments
9.7 Teikoku Pharma
9.7.1 Teikoku Pharma Post Herpetic Neuralgia Therapies Basic Information
9.7.2 Teikoku Pharma Post Herpetic Neuralgia Therapies Product Overview
9.7.3 Teikoku Pharma Post Herpetic Neuralgia Therapies Product Market Performance
9.7.4 Teikoku Pharma Business Overview
9.7.5 Teikoku Pharma Recent Developments
10 POST HERPETIC NEURALGIA THERAPIES MARKET FORECAST BY REGION
10.1 Global Post Herpetic Neuralgia Therapies Market Size Forecast
10.2 Global Post Herpetic Neuralgia Therapies Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Post Herpetic Neuralgia Therapies Market Size Forecast by Country
10.2.3 Asia Pacific Post Herpetic Neuralgia Therapies Market Size Forecast by Region
10.2.4 South America Post Herpetic Neuralgia Therapies Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Post Herpetic Neuralgia Therapies by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Post Herpetic Neuralgia Therapies Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Post Herpetic Neuralgia Therapies by Type (2025-2030)
11.1.2 Global Post Herpetic Neuralgia Therapies Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Post Herpetic Neuralgia Therapies by Type (2025-2030)
11.2 Global Post Herpetic Neuralgia Therapies Market Forecast by Application (2025-2030)
11.2.1 Global Post Herpetic Neuralgia Therapies Sales (K Units) Forecast by Application
11.2.2 Global Post Herpetic Neuralgia Therapies Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Post Herpetic Neuralgia Therapies
1.2 Key Market Segments
1.2.1 Post Herpetic Neuralgia Therapies Segment by Type
1.2.2 Post Herpetic Neuralgia Therapies Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 POST HERPETIC NEURALGIA THERAPIES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Post Herpetic Neuralgia Therapies Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Post Herpetic Neuralgia Therapies Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 POST HERPETIC NEURALGIA THERAPIES MARKET COMPETITIVE LANDSCAPE
3.1 Global Post Herpetic Neuralgia Therapies Sales by Manufacturers (2019-2024)
3.2 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Manufacturers (2019-2024)
3.3 Post Herpetic Neuralgia Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Post Herpetic Neuralgia Therapies Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Post Herpetic Neuralgia Therapies Sales Sites, Area Served, Product Type
3.6 Post Herpetic Neuralgia Therapies Market Competitive Situation and Trends
3.6.1 Post Herpetic Neuralgia Therapies Market Concentration Rate
3.6.2 Global 5 and 10 Largest Post Herpetic Neuralgia Therapies Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 POST HERPETIC NEURALGIA THERAPIES INDUSTRY CHAIN ANALYSIS
4.1 Post Herpetic Neuralgia Therapies Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF POST HERPETIC NEURALGIA THERAPIES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 POST HERPETIC NEURALGIA THERAPIES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Post Herpetic Neuralgia Therapies Sales Market Share by Type (2019-2024)
6.3 Global Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2019-2024)
6.4 Global Post Herpetic Neuralgia Therapies Price by Type (2019-2024)
7 POST HERPETIC NEURALGIA THERAPIES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Post Herpetic Neuralgia Therapies Market Sales by Application (2019-2024)
7.3 Global Post Herpetic Neuralgia Therapies Market Size (M USD) by Application (2019-2024)
7.4 Global Post Herpetic Neuralgia Therapies Sales Growth Rate by Application (2019-2024)
8 POST HERPETIC NEURALGIA THERAPIES MARKET SEGMENTATION BY REGION
8.1 Global Post Herpetic Neuralgia Therapies Sales by Region
8.1.1 Global Post Herpetic Neuralgia Therapies Sales by Region
8.1.2 Global Post Herpetic Neuralgia Therapies Sales Market Share by Region
8.2 North America
8.2.1 North America Post Herpetic Neuralgia Therapies Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Post Herpetic Neuralgia Therapies Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Post Herpetic Neuralgia Therapies Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Post Herpetic Neuralgia Therapies Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Post Herpetic Neuralgia Therapies Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Endo Pharmaceuticals
9.1.1 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Basic Information
9.1.2 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Product Overview
9.1.3 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Product Market Performance
9.1.4 Endo Pharmaceuticals Business Overview
9.1.5 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies SWOT Analysis
9.1.6 Endo Pharmaceuticals Recent Developments
9.2 Depomed
9.2.1 Depomed Post Herpetic Neuralgia Therapies Basic Information
9.2.2 Depomed Post Herpetic Neuralgia Therapies Product Overview
9.2.3 Depomed Post Herpetic Neuralgia Therapies Product Market Performance
9.2.4 Depomed Business Overview
9.2.5 Depomed Post Herpetic Neuralgia Therapies SWOT Analysis
9.2.6 Depomed Recent Developments
9.3 Acorda Therapeutics
9.3.1 Acorda Therapeutics Post Herpetic Neuralgia Therapies Basic Information
9.3.2 Acorda Therapeutics Post Herpetic Neuralgia Therapies Product Overview
9.3.3 Acorda Therapeutics Post Herpetic Neuralgia Therapies Product Market Performance
9.3.4 Acorda Therapeutics Post Herpetic Neuralgia Therapies SWOT Analysis
9.3.5 Acorda Therapeutics Business Overview
9.3.6 Acorda Therapeutics Recent Developments
9.4 Pfizer
9.4.1 Pfizer Post Herpetic Neuralgia Therapies Basic Information
9.4.2 Pfizer Post Herpetic Neuralgia Therapies Product Overview
9.4.3 Pfizer Post Herpetic Neuralgia Therapies Product Market Performance
9.4.4 Pfizer Business Overview
9.4.5 Pfizer Recent Developments
9.5 Mylan
9.5.1 Mylan Post Herpetic Neuralgia Therapies Basic Information
9.5.2 Mylan Post Herpetic Neuralgia Therapies Product Overview
9.5.3 Mylan Post Herpetic Neuralgia Therapies Product Market Performance
9.5.4 Mylan Business Overview
9.5.5 Mylan Recent Developments
9.6 Daiichi Sankyo
9.6.1 Daiichi Sankyo Post Herpetic Neuralgia Therapies Basic Information
9.6.2 Daiichi Sankyo Post Herpetic Neuralgia Therapies Product Overview
9.6.3 Daiichi Sankyo Post Herpetic Neuralgia Therapies Product Market Performance
9.6.4 Daiichi Sankyo Business Overview
9.6.5 Daiichi Sankyo Recent Developments
9.7 Teikoku Pharma
9.7.1 Teikoku Pharma Post Herpetic Neuralgia Therapies Basic Information
9.7.2 Teikoku Pharma Post Herpetic Neuralgia Therapies Product Overview
9.7.3 Teikoku Pharma Post Herpetic Neuralgia Therapies Product Market Performance
9.7.4 Teikoku Pharma Business Overview
9.7.5 Teikoku Pharma Recent Developments
10 POST HERPETIC NEURALGIA THERAPIES MARKET FORECAST BY REGION
10.1 Global Post Herpetic Neuralgia Therapies Market Size Forecast
10.2 Global Post Herpetic Neuralgia Therapies Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Post Herpetic Neuralgia Therapies Market Size Forecast by Country
10.2.3 Asia Pacific Post Herpetic Neuralgia Therapies Market Size Forecast by Region
10.2.4 South America Post Herpetic Neuralgia Therapies Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Post Herpetic Neuralgia Therapies by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Post Herpetic Neuralgia Therapies Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Post Herpetic Neuralgia Therapies by Type (2025-2030)
11.1.2 Global Post Herpetic Neuralgia Therapies Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Post Herpetic Neuralgia Therapies by Type (2025-2030)
11.2 Global Post Herpetic Neuralgia Therapies Market Forecast by Application (2025-2030)
11.2.1 Global Post Herpetic Neuralgia Therapies Sales (K Units) Forecast by Application
11.2.2 Global Post Herpetic Neuralgia Therapies Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Post Herpetic Neuralgia Therapies Market Size Comparison by Region (M USD)
Table 5. Global Post Herpetic Neuralgia Therapies Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Post Herpetic Neuralgia Therapies Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Post Herpetic Neuralgia Therapies Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Post Herpetic Neuralgia Therapies Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post Herpetic Neuralgia Therapies as of 2022)
Table 10. Global Market Post Herpetic Neuralgia Therapies Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Post Herpetic Neuralgia Therapies Sales Sites and Area Served
Table 12. Manufacturers Post Herpetic Neuralgia Therapies Product Type
Table 13. Global Post Herpetic Neuralgia Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Post Herpetic Neuralgia Therapies
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Post Herpetic Neuralgia Therapies Market Challenges
Table 22. Global Post Herpetic Neuralgia Therapies Sales by Type (K Units)
Table 23. Global Post Herpetic Neuralgia Therapies Market Size by Type (M USD)
Table 24. Global Post Herpetic Neuralgia Therapies Sales (K Units) by Type (2019-2024)
Table 25. Global Post Herpetic Neuralgia Therapies Sales Market Share by Type (2019-2024)
Table 26. Global Post Herpetic Neuralgia Therapies Market Size (M USD) by Type (2019-2024)
Table 27. Global Post Herpetic Neuralgia Therapies Market Size Share by Type (2019-2024)
Table 28. Global Post Herpetic Neuralgia Therapies Price (USD/Unit) by Type (2019-2024)
Table 29. Global Post Herpetic Neuralgia Therapies Sales (K Units) by Application
Table 30. Global Post Herpetic Neuralgia Therapies Market Size by Application
Table 31. Global Post Herpetic Neuralgia Therapies Sales by Application (2019-2024) & (K Units)
Table 32. Global Post Herpetic Neuralgia Therapies Sales Market Share by Application (2019-2024)
Table 33. Global Post Herpetic Neuralgia Therapies Sales by Application (2019-2024) & (M USD)
Table 34. Global Post Herpetic Neuralgia Therapies Market Share by Application (2019-2024)
Table 35. Global Post Herpetic Neuralgia Therapies Sales Growth Rate by Application (2019-2024)
Table 36. Global Post Herpetic Neuralgia Therapies Sales by Region (2019-2024) & (K Units)
Table 37. Global Post Herpetic Neuralgia Therapies Sales Market Share by Region (2019-2024)
Table 38. North America Post Herpetic Neuralgia Therapies Sales by Country (2019-2024) & (K Units)
Table 39. Europe Post Herpetic Neuralgia Therapies Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Post Herpetic Neuralgia Therapies Sales by Region (2019-2024) & (K Units)
Table 41. South America Post Herpetic Neuralgia Therapies Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Post Herpetic Neuralgia Therapies Sales by Region (2019-2024) & (K Units)
Table 43. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Basic Information
Table 44. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Product Overview
Table 45. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Endo Pharmaceuticals Business Overview
Table 47. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies SWOT Analysis
Table 48. Endo Pharmaceuticals Recent Developments
Table 49. Depomed Post Herpetic Neuralgia Therapies Basic Information
Table 50. Depomed Post Herpetic Neuralgia Therapies Product Overview
Table 51. Depomed Post Herpetic Neuralgia Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Depomed Business Overview
Table 53. Depomed Post Herpetic Neuralgia Therapies SWOT Analysis
Table 54. Depomed Recent Developments
Table 55. Acorda Therapeutics Post Herpetic Neuralgia Therapies Basic Information
Table 56. Acorda Therapeutics Post Herpetic Neuralgia Therapies Product Overview
Table 57. Acorda Therapeutics Post Herpetic Neuralgia Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Acorda Therapeutics Post Herpetic Neuralgia Therapies SWOT Analysis
Table 59. Acorda Therapeutics Business Overview
Table 60. Acorda Therapeutics Recent Developments
Table 61. Pfizer Post Herpetic Neuralgia Therapies Basic Information
Table 62. Pfizer Post Herpetic Neuralgia Therapies Product Overview
Table 63. Pfizer Post Herpetic Neuralgia Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Pfizer Business Overview
Table 65. Pfizer Recent Developments
Table 66. Mylan Post Herpetic Neuralgia Therapies Basic Information
Table 67. Mylan Post Herpetic Neuralgia Therapies Product Overview
Table 68. Mylan Post Herpetic Neuralgia Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Mylan Business Overview
Table 70. Mylan Recent Developments
Table 71. Daiichi Sankyo Post Herpetic Neuralgia Therapies Basic Information
Table 72. Daiichi Sankyo Post Herpetic Neuralgia Therapies Product Overview
Table 73. Daiichi Sankyo Post Herpetic Neuralgia Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Daiichi Sankyo Business Overview
Table 75. Daiichi Sankyo Recent Developments
Table 76. Teikoku Pharma Post Herpetic Neuralgia Therapies Basic Information
Table 77. Teikoku Pharma Post Herpetic Neuralgia Therapies Product Overview
Table 78. Teikoku Pharma Post Herpetic Neuralgia Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Teikoku Pharma Business Overview
Table 80. Teikoku Pharma Recent Developments
Table 81. Global Post Herpetic Neuralgia Therapies Sales Forecast by Region (2025-2030) & (K Units)
Table 82. Global Post Herpetic Neuralgia Therapies Market Size Forecast by Region (2025-2030) & (M USD)
Table 83. North America Post Herpetic Neuralgia Therapies Sales Forecast by Country (2025-2030) & (K Units)
Table 84. North America Post Herpetic Neuralgia Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 85. Europe Post Herpetic Neuralgia Therapies Sales Forecast by Country (2025-2030) & (K Units)
Table 86. Europe Post Herpetic Neuralgia Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 87. Asia Pacific Post Herpetic Neuralgia Therapies Sales Forecast by Region (2025-2030) & (K Units)
Table 88. Asia Pacific Post Herpetic Neuralgia Therapies Market Size Forecast by Region (2025-2030) & (M USD)
Table 89. South America Post Herpetic Neuralgia Therapies Sales Forecast by Country (2025-2030) & (K Units)
Table 90. South America Post Herpetic Neuralgia Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 91. Middle East and Africa Post Herpetic Neuralgia Therapies Consumption Forecast by Country (2025-2030) & (Units)
Table 92. Middle East and Africa Post Herpetic Neuralgia Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 93. Global Post Herpetic Neuralgia Therapies Sales Forecast by Type (2025-2030) & (K Units)
Table 94. Global Post Herpetic Neuralgia Therapies Market Size Forecast by Type (2025-2030) & (M USD)
Table 95. Global Post Herpetic Neuralgia Therapies Price Forecast by Type (2025-2030) & (USD/Unit)
Table 96. Global Post Herpetic Neuralgia Therapies Sales (K Units) Forecast by Application (2025-2030)
Table 97. Global Post Herpetic Neuralgia Therapies Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Post Herpetic Neuralgia Therapies Market Size Comparison by Region (M USD)
Table 5. Global Post Herpetic Neuralgia Therapies Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Post Herpetic Neuralgia Therapies Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Post Herpetic Neuralgia Therapies Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Post Herpetic Neuralgia Therapies Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post Herpetic Neuralgia Therapies as of 2022)
Table 10. Global Market Post Herpetic Neuralgia Therapies Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Post Herpetic Neuralgia Therapies Sales Sites and Area Served
Table 12. Manufacturers Post Herpetic Neuralgia Therapies Product Type
Table 13. Global Post Herpetic Neuralgia Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Post Herpetic Neuralgia Therapies
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Post Herpetic Neuralgia Therapies Market Challenges
Table 22. Global Post Herpetic Neuralgia Therapies Sales by Type (K Units)
Table 23. Global Post Herpetic Neuralgia Therapies Market Size by Type (M USD)
Table 24. Global Post Herpetic Neuralgia Therapies Sales (K Units) by Type (2019-2024)
Table 25. Global Post Herpetic Neuralgia Therapies Sales Market Share by Type (2019-2024)
Table 26. Global Post Herpetic Neuralgia Therapies Market Size (M USD) by Type (2019-2024)
Table 27. Global Post Herpetic Neuralgia Therapies Market Size Share by Type (2019-2024)
Table 28. Global Post Herpetic Neuralgia Therapies Price (USD/Unit) by Type (2019-2024)
Table 29. Global Post Herpetic Neuralgia Therapies Sales (K Units) by Application
Table 30. Global Post Herpetic Neuralgia Therapies Market Size by Application
Table 31. Global Post Herpetic Neuralgia Therapies Sales by Application (2019-2024) & (K Units)
Table 32. Global Post Herpetic Neuralgia Therapies Sales Market Share by Application (2019-2024)
Table 33. Global Post Herpetic Neuralgia Therapies Sales by Application (2019-2024) & (M USD)
Table 34. Global Post Herpetic Neuralgia Therapies Market Share by Application (2019-2024)
Table 35. Global Post Herpetic Neuralgia Therapies Sales Growth Rate by Application (2019-2024)
Table 36. Global Post Herpetic Neuralgia Therapies Sales by Region (2019-2024) & (K Units)
Table 37. Global Post Herpetic Neuralgia Therapies Sales Market Share by Region (2019-2024)
Table 38. North America Post Herpetic Neuralgia Therapies Sales by Country (2019-2024) & (K Units)
Table 39. Europe Post Herpetic Neuralgia Therapies Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Post Herpetic Neuralgia Therapies Sales by Region (2019-2024) & (K Units)
Table 41. South America Post Herpetic Neuralgia Therapies Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Post Herpetic Neuralgia Therapies Sales by Region (2019-2024) & (K Units)
Table 43. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Basic Information
Table 44. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Product Overview
Table 45. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Endo Pharmaceuticals Business Overview
Table 47. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies SWOT Analysis
Table 48. Endo Pharmaceuticals Recent Developments
Table 49. Depomed Post Herpetic Neuralgia Therapies Basic Information
Table 50. Depomed Post Herpetic Neuralgia Therapies Product Overview
Table 51. Depomed Post Herpetic Neuralgia Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Depomed Business Overview
Table 53. Depomed Post Herpetic Neuralgia Therapies SWOT Analysis
Table 54. Depomed Recent Developments
Table 55. Acorda Therapeutics Post Herpetic Neuralgia Therapies Basic Information
Table 56. Acorda Therapeutics Post Herpetic Neuralgia Therapies Product Overview
Table 57. Acorda Therapeutics Post Herpetic Neuralgia Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Acorda Therapeutics Post Herpetic Neuralgia Therapies SWOT Analysis
Table 59. Acorda Therapeutics Business Overview
Table 60. Acorda Therapeutics Recent Developments
Table 61. Pfizer Post Herpetic Neuralgia Therapies Basic Information
Table 62. Pfizer Post Herpetic Neuralgia Therapies Product Overview
Table 63. Pfizer Post Herpetic Neuralgia Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Pfizer Business Overview
Table 65. Pfizer Recent Developments
Table 66. Mylan Post Herpetic Neuralgia Therapies Basic Information
Table 67. Mylan Post Herpetic Neuralgia Therapies Product Overview
Table 68. Mylan Post Herpetic Neuralgia Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Mylan Business Overview
Table 70. Mylan Recent Developments
Table 71. Daiichi Sankyo Post Herpetic Neuralgia Therapies Basic Information
Table 72. Daiichi Sankyo Post Herpetic Neuralgia Therapies Product Overview
Table 73. Daiichi Sankyo Post Herpetic Neuralgia Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Daiichi Sankyo Business Overview
Table 75. Daiichi Sankyo Recent Developments
Table 76. Teikoku Pharma Post Herpetic Neuralgia Therapies Basic Information
Table 77. Teikoku Pharma Post Herpetic Neuralgia Therapies Product Overview
Table 78. Teikoku Pharma Post Herpetic Neuralgia Therapies Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Teikoku Pharma Business Overview
Table 80. Teikoku Pharma Recent Developments
Table 81. Global Post Herpetic Neuralgia Therapies Sales Forecast by Region (2025-2030) & (K Units)
Table 82. Global Post Herpetic Neuralgia Therapies Market Size Forecast by Region (2025-2030) & (M USD)
Table 83. North America Post Herpetic Neuralgia Therapies Sales Forecast by Country (2025-2030) & (K Units)
Table 84. North America Post Herpetic Neuralgia Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 85. Europe Post Herpetic Neuralgia Therapies Sales Forecast by Country (2025-2030) & (K Units)
Table 86. Europe Post Herpetic Neuralgia Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 87. Asia Pacific Post Herpetic Neuralgia Therapies Sales Forecast by Region (2025-2030) & (K Units)
Table 88. Asia Pacific Post Herpetic Neuralgia Therapies Market Size Forecast by Region (2025-2030) & (M USD)
Table 89. South America Post Herpetic Neuralgia Therapies Sales Forecast by Country (2025-2030) & (K Units)
Table 90. South America Post Herpetic Neuralgia Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 91. Middle East and Africa Post Herpetic Neuralgia Therapies Consumption Forecast by Country (2025-2030) & (Units)
Table 92. Middle East and Africa Post Herpetic Neuralgia Therapies Market Size Forecast by Country (2025-2030) & (M USD)
Table 93. Global Post Herpetic Neuralgia Therapies Sales Forecast by Type (2025-2030) & (K Units)
Table 94. Global Post Herpetic Neuralgia Therapies Market Size Forecast by Type (2025-2030) & (M USD)
Table 95. Global Post Herpetic Neuralgia Therapies Price Forecast by Type (2025-2030) & (USD/Unit)
Table 96. Global Post Herpetic Neuralgia Therapies Sales (K Units) Forecast by Application (2025-2030)
Table 97. Global Post Herpetic Neuralgia Therapies Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Post Herpetic Neuralgia Therapies
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Post Herpetic Neuralgia Therapies Market Size (M USD), 2019-2030
Figure 5. Global Post Herpetic Neuralgia Therapies Market Size (M USD) (2019-2030)
Figure 6. Global Post Herpetic Neuralgia Therapies Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Post Herpetic Neuralgia Therapies Market Size by Country (M USD)
Figure 11. Post Herpetic Neuralgia Therapies Sales Share by Manufacturers in 2023
Figure 12. Global Post Herpetic Neuralgia Therapies Revenue Share by Manufacturers in 2023
Figure 13. Post Herpetic Neuralgia Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Post Herpetic Neuralgia Therapies Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Post Herpetic Neuralgia Therapies Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Post Herpetic Neuralgia Therapies Market Share by Type
Figure 18. Sales Market Share of Post Herpetic Neuralgia Therapies by Type (2019-2024)
Figure 19. Sales Market Share of Post Herpetic Neuralgia Therapies by Type in 2023
Figure 20. Market Size Share of Post Herpetic Neuralgia Therapies by Type (2019-2024)
Figure 21. Market Size Market Share of Post Herpetic Neuralgia Therapies by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Post Herpetic Neuralgia Therapies Market Share by Application
Figure 24. Global Post Herpetic Neuralgia Therapies Sales Market Share by Application (2019-2024)
Figure 25. Global Post Herpetic Neuralgia Therapies Sales Market Share by Application in 2023
Figure 26. Global Post Herpetic Neuralgia Therapies Market Share by Application (2019-2024)
Figure 27. Global Post Herpetic Neuralgia Therapies Market Share by Application in 2023
Figure 28. Global Post Herpetic Neuralgia Therapies Sales Growth Rate by Application (2019-2024)
Figure 29. Global Post Herpetic Neuralgia Therapies Sales Market Share by Region (2019-2024)
Figure 30. North America Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Post Herpetic Neuralgia Therapies Sales Market Share by Country in 2023
Figure 32. U.S. Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Post Herpetic Neuralgia Therapies Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Post Herpetic Neuralgia Therapies Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Post Herpetic Neuralgia Therapies Sales Market Share by Country in 2023
Figure 37. Germany Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Post Herpetic Neuralgia Therapies Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Post Herpetic Neuralgia Therapies Sales Market Share by Region in 2023
Figure 44. China Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Post Herpetic Neuralgia Therapies Sales and Growth Rate (K Units)
Figure 50. South America Post Herpetic Neuralgia Therapies Sales Market Share by Country in 2023
Figure 51. Brazil Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Post Herpetic Neuralgia Therapies Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Post Herpetic Neuralgia Therapies Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Post Herpetic Neuralgia Therapies Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Post Herpetic Neuralgia Therapies Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Post Herpetic Neuralgia Therapies Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Post Herpetic Neuralgia Therapies Market Share Forecast by Type (2025-2030)
Figure 65. Global Post Herpetic Neuralgia Therapies Sales Forecast by Application (2025-2030)
Figure 66. Global Post Herpetic Neuralgia Therapies Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Post Herpetic Neuralgia Therapies
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Post Herpetic Neuralgia Therapies Market Size (M USD), 2019-2030
Figure 5. Global Post Herpetic Neuralgia Therapies Market Size (M USD) (2019-2030)
Figure 6. Global Post Herpetic Neuralgia Therapies Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Post Herpetic Neuralgia Therapies Market Size by Country (M USD)
Figure 11. Post Herpetic Neuralgia Therapies Sales Share by Manufacturers in 2023
Figure 12. Global Post Herpetic Neuralgia Therapies Revenue Share by Manufacturers in 2023
Figure 13. Post Herpetic Neuralgia Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Post Herpetic Neuralgia Therapies Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Post Herpetic Neuralgia Therapies Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Post Herpetic Neuralgia Therapies Market Share by Type
Figure 18. Sales Market Share of Post Herpetic Neuralgia Therapies by Type (2019-2024)
Figure 19. Sales Market Share of Post Herpetic Neuralgia Therapies by Type in 2023
Figure 20. Market Size Share of Post Herpetic Neuralgia Therapies by Type (2019-2024)
Figure 21. Market Size Market Share of Post Herpetic Neuralgia Therapies by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Post Herpetic Neuralgia Therapies Market Share by Application
Figure 24. Global Post Herpetic Neuralgia Therapies Sales Market Share by Application (2019-2024)
Figure 25. Global Post Herpetic Neuralgia Therapies Sales Market Share by Application in 2023
Figure 26. Global Post Herpetic Neuralgia Therapies Market Share by Application (2019-2024)
Figure 27. Global Post Herpetic Neuralgia Therapies Market Share by Application in 2023
Figure 28. Global Post Herpetic Neuralgia Therapies Sales Growth Rate by Application (2019-2024)
Figure 29. Global Post Herpetic Neuralgia Therapies Sales Market Share by Region (2019-2024)
Figure 30. North America Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Post Herpetic Neuralgia Therapies Sales Market Share by Country in 2023
Figure 32. U.S. Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Post Herpetic Neuralgia Therapies Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Post Herpetic Neuralgia Therapies Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Post Herpetic Neuralgia Therapies Sales Market Share by Country in 2023
Figure 37. Germany Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Post Herpetic Neuralgia Therapies Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Post Herpetic Neuralgia Therapies Sales Market Share by Region in 2023
Figure 44. China Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Post Herpetic Neuralgia Therapies Sales and Growth Rate (K Units)
Figure 50. South America Post Herpetic Neuralgia Therapies Sales Market Share by Country in 2023
Figure 51. Brazil Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Post Herpetic Neuralgia Therapies Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Post Herpetic Neuralgia Therapies Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Post Herpetic Neuralgia Therapies Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Post Herpetic Neuralgia Therapies Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Post Herpetic Neuralgia Therapies Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Post Herpetic Neuralgia Therapies Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Post Herpetic Neuralgia Therapies Market Share Forecast by Type (2025-2030)
Figure 65. Global Post Herpetic Neuralgia Therapies Sales Forecast by Application (2025-2030)
Figure 66. Global Post Herpetic Neuralgia Therapies Market Share Forecast by Application (2025-2030)
